1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Acalabrutinib and Durvalumab in Primary and Secondary Central Nervous System Lymphomaprimary central nervous system lymphomaActive, not recruitingPhase 12026-09-16NCT04462328